19
BioTOPics 46 | September 2013
BioTOP-Report
Diagnostics
chow-Klinikum. More than 10,000 hospital beds in and around
Berlin will be provided with high-performance diagnostics from
this new location.
Efficient technology transfer based on regional
networks
“BioResponse” and “DiagnostikNet BB” have emerged as compa-
ny-driven networks whose intensive cooperation with science
has resulted in innovative product developments like the AK-
LIDES system, which have become international market leaders.
The Centre for Molecular Diagnostics and Bioanalysis (ZMDB) has
driven regional and international cooperation between science
and industry as a successful platform for know-how and technol-
ogy transfer since 2009. Through the ZMDB, Berlin-Brandenburg
has maintained close links with nine leading European diagnos-
tics regions since 2010 as part of the European Diagnostics Clus-
ter Alliance (EDCA), offering regional SMEs specific market access
support services.
The Technology Forum In vitro-Diagnostics and Bioanalysis organ-
ised by the ZMDB has been held in the capital region for the past
five years and is proving to be an excellent platform for initiating
sustainable dialogue between fundamental research and indus-
trial as well as clinical application. The 5th Technology Forum in
June 2013 focused on mass spectrometry, protein arrays and ap-
tamer-based biosensors. A specially designed partnering event
for diagnostics companies and research institutes permitted
meeting new cooperation partners from Europe and was aimed
at fostering and encouraging potential growth opportunities.
Ene
rgy
Aut
omation
Phot
onics
Indus
trial Sof
tware
Sof
twa
re
Inter
net & T
elecommunication
Media & E-commerce
Life Science
Mater
ial Science
Nanotechnology & Chemis
try
I N V E S T O R S O F H I G H - T E C H G R U E N D E R F O N D S I I
Achieve innovation,
shape the future
High Tech Gruenderfonds is your partner for Seed Stage investing. We
help out young, high potential startups in the early phases of technology
and product development, as well as successful launching. Our assistance
is not limited to our cash investments, instead we strive to add long term
added-value to portfolio companies through our extensive network of
professional and our accredited coaches.
High-Tech Gründerfonds Management GmbH
Schlegelstraße 2 | 53113 Bonn
Phone: +49 (0)228-823001-00 | Fax: +49 (0)228-823000-50
E-Mail: info@htgf.de
http: // www.high-tech-gruenderfonds.de
Start shot for young technology companies
20
BioTOPics 46 | September 2013
BioTOP-Report
PAREXEL International
PAREXEL International is a leading global
bio/pharmaceutical services organization,
providing a broad range of knowledge-based
contract research, consulting and medical
communications services to the worldwide
pharmaceutical, biotechnology and medical
device industries. Committed to providing
solutions that expedite time-to-market and
peak-market penetration, PAREXEL has
developed significant expertise across the
development and commercialization contin-
uum, from drug development and regulatory
consulting to clinical pharmacology, clinical
trials management, medical education and
reimbursement. Perceptive Informatics, Inc.,
a subsidiary of PAREXEL, provides advanced
technology solutions, including medical
imaging, to facilitate the clinical develop-
ment process. Headquartered near Boston,
Massachusetts, PAREXEL operates in 78
locations throughout 52 countries around
the world, and has approximately 14,400
employees.
PAREXEL has a long-standing presence in
Berlin, where over 1,500 employees are
located. Clients can benefit from state-of-
the-art technologies and equipment provid-
ed through PAREXEL’s medical imaging lab
and Early Phase Units, which provide a safe,
high-quality environment for early phase
development activities in a hospital setting.
The PAREXEL Academy located in Berlin
qualifies clinical research associates and
clinical data managers, and offers a course
for a Bachelor of Science degree in Clinical
Research, validated by a British university.
Address
PAREXEL International GmbH
Klinikum Westend · Haus 18
Spandauer Damm 130
14050 Berlin · Germany
Contact
Dr. Ulf Schneider
Corporate Senior Vice President and Chief
Administrative Officer
Phone +49 30 30685 115
Fax
+49 30 30685 7115
Ulf.Schneider@PAREXEL.com
www.PAREXEL.com
Dr. Notghi Contract Research GmbH
Full service CRO
Dr. Notghi Contract Research GmbH is a high
quality service provider for large, medium
and small-sized companies in the pharma-
ceutical, generics and biotechnology indus-
tries. Our full-service offerings include Sta-
tistics, Clinical Monitoring, Medical Writing,
Data Management, Study Management,
Pharmacovigilance, Regulatory Affairs, IT
Solutions, & Training Solutions.
For 14 years, our clients have benefited
from our broad expertise in clinical research
to meet their business challenges. We have
successfully supported and advised hundred
of companies in the conduct and manage-
ment of national and international projects,
enabling them to bring their reliable and
successful products to market in ever short-
er periods of time.
Founded by Dr. Arman Notghi, the company
has its headquarters in Berlin as well as an
office in Istanbul, Turkey. Dr. Notghi Contract
Research GmbH has enjoyed continuous
and stable growth thanks to the confidence
placed in us by our longstanding customers
and the dedication of our employees. With
over 90 specialized employees available
across Europe for our clients, we can rapidly
and efficiently respond to a wide range of
requirements. The Dr. Notghi Academy,
located in Berlin, qualifies drug safety offi-
cers, clinical research associates and data
managers, offers specialist workshops and
global learning & development solutions for
the Pharmaceutical industry.
Address
Dr. Notghi Contract Research GmbH
Zimmerstraße 55
10117 Berlin
Contact
Melanie Wurzel · Deputy CEO
Phone +49 30 460 64 725
Fax
+49 30 460 64 733
contact@notghi.com
www.notghi.com
Benefit from
our Compet
ence